These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4131429)

  • 1. Rifampicin hepatitis. A clinical and histological study.
    Scheuer PJ; Summerfield JA; Lal S; Sherlock S
    Lancet; 1974 Mar; 1(7855):421-5. PubMed ID: 4131429
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
    Favez G; Chioléro R; Willa C
    Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
    [No Abstract]   [Full Text] [Related]  

  • 6. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatoxic side-effects of rifampicin. A comparative clinical study].
    Kuntz HD; Rausch V
    Med Welt; 1977 Nov; 28(47):1940-2. PubMed ID: 342868
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent rifampicin treatment of tuberculosis.
    Riska N; Mattson K
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis therapy.
    Lefrock JL; Smith BR
    Am Fam Physician; 1983 Mar; 27(3):261-4. PubMed ID: 6829397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Ugeskr Laeger; 1973 Aug; 135(34):1795-9. PubMed ID: 4592618
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
    Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
    Yew WW; Lee J; Wong PC; Kwan SY
    Int J Clin Pharmacol Res; 1992; 12(4):173-8. PubMed ID: 1297640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late results following rifampicin therapy and tolerance of rifampicin given on a long-term basis.
    Flemming J; Virchow C
    Respiration; 1971; 28():Suppl:107-15. PubMed ID: 5150790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis induced by combination of rifampicin and isoniazid].
    Marche J; Hugues FC; Graisely B; Marche C
    Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5146732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 19. [Jaundice and rifampicin].
    Piéron R; Marien C; Jagueux M
    Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.